Research
Education
Solutions
Sign In
EN
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Department of Gastrointestinal Surgery
Hideyuki Ohzawa has not added Biography.
If you are Hideyuki Ohzawa and would like to personalize this page please email our Author Liaison for assistance.
Pathological responses and survival of patients with human epidermal growth factor receptor 2-positive breast cancer who received neoadjuvant chemotherapy including trastuzumab.
Breast cancer (Tokyo, Japan) Sep, 2014 | Pubmed ID: 23108629
[Quality assurance in HER2 testing].
Nihon rinsho. Japanese journal of clinical medicine Sep, 2012 | Pubmed ID: 23350434
Comparison between the antiemetic effects of palonosetron and granisetron in breast cancer patients treated with anthracycline-based regimens.
Oncology letters Jan, 2015 | Pubmed ID: 25435944
Immunoglobulin G4-related sclerosing cholangitis mimicking hilar cholangiocarcinoma diagnosed with following bile duct resection: report of a case.
International surgery Mar, 2015 | Pubmed ID: 25785331
Usefulness of miRNA profiles for predicting pathological responses to neoadjuvant chemotherapy in patients with human epidermal growth factor receptor 2-positive breast cancer.
Oncology letters Mar, 2017 | Pubmed ID: 28454317
Low density neutrophils (LDN) in postoperative abdominal cavity assist the peritoneal recurrence through the production of neutrophil extracellular traps (NETs).
Scientific reports Jan, 2018 | Pubmed ID: 29330531
Jichi Medical University
Rihito Kanamaru1,
Hideyuki Ohzawa1,
Hideyo Miyato1,
Hironori Yamaguchi1,
Yoshinori Hosoya1,
Alan Kawarai Lefor1,
Naohiro Sata1,
Joji Kitayama1
1Department of Gastrointestinal Surgery, Jichi Medical University
Privacy
Terms of Use
Policies
Contact Us
Recommend to library
JoVE NEWSLETTERS
JoVE Journal
Methods Collections
JoVE Encyclopedia of Experiments
Archive
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Faculty Resource Center
Authors
Librarians
Access
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved